Search
Generation Bio Co
GBIOAdd to Watchlist
5.340USD
0.0000.00%
Market hours （ET）Quotes delayed by 15 min
35.98MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-02-06The current earnings forecast score of Generation Bio Co is 7.00, ranking 311 out of 392 in the Biotechnology & Medical Research industry. The average price target is 11.00, with a high of 70.00 and a low of 10.00.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
8.250
Target Price
+54.49%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Generation Bio Co
GBIO
3
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Generation Bio Co's expected revenue for the next quarter?
Generation Bio Co's expected revenue is 433.33K.
What is Generation Bio Co's price target?
Analysts forecast that Generation Bio Co's price target is USD 11.00, with the highest forecast at USD 70.00 and the lowest forecast at USD 10.00.
How have Generation Bio CoGBIO's recent earnings per share performed?
The market expectation was USD -0.82, while Generation Bio CoGBIO's earnings per share (EPS) for the previous quarter was USD -31.20. EPS for the next quarter is expected at USD -4.91.
What is the analyst rating for Generation Bio Co?
Based on the ratings of Generation Bio Co's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.